Ultralife Corporation (ULBI) financial statements and ratios from SEC XBRL: revenue $191.16M (TTM), net margin -3.1%, revenue growth -1.3% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $191.16M |
| Net Margin | -3.1% |
| Revenue Growth (YoY) | -1.3% |
| EPS Growth (YoY) | 29900.0% |
| FCF Growth (YoY) | -84.8% |
| Price / Book | 0.87 |
| Price / Sales | 0.62 |
| FCF Yield | 1.8% |
| DCF Value (model) | $12.05 |
| DCF Upside vs Price | 74.3% |
| Altman Z-Score | 1.71 (distress) |
| Piotroski F-Score | 4/9 |
| Sector P/E (Industrials) | 25.9 |
ULBI overview · ULBI earnings · ULBI KPIs · ULBI investor relations · ULBI ownership · ULBI peers · ULBI filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.